Early Treatment Can Postpone the Time to Disability Pension in Relapsing-Remitting Multiple Sclerosis

被引：0
|
作者：
Wandall-Holm, Malthe [1 ]
Buron, Mathias [1 ]
Kopp, Tine Iskov [1 ]
Sellebjerg, Finn [2 ]
Magyari, Melinda [1 ,2 ]
机构：
[1] Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Danish Multiple Sclerosis Registry, Glostrup, Denmark
[2] Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Danish Multiple Sclerosis Ctr, Glostrup, Denmark
来源：
NEUROLOGY | 2022年 / 98卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P17-4.002
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Early treatment can postpone the time to disability pension in relapsing-remitting multiple sclerosis
    Wandall-Holm, M.
    Kopp, T. Iskov
    Buron, M. Due
    Sellebjerg, F.
    Magyari, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 63 - 63
  • [2] Time to first treatment and risk of disability pension in relapsing-remitting multiple sclerosis
    Wandall-Holm, Malthe Faurschou
    Buron, Mathias Due
    Kopp, Tine Iskov
    Thielen, Karsten
    Sellebjerg, Finn
    Magyari, Melinda
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (08): : 858 - 864
  • [3] PROGNOSIS OF DISABILITY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Somilo, O., V
    Kalbus, O., I
    Makarov, S. O.
    Sorokin, A. V.
    Shastun, N. P.
    [J]. WORLD OF MEDICINE AND BIOLOGY, 2023, 84 (02): : 147 - 152
  • [4] Disability trajectories in relapsing-remitting multiple sclerosis
    Uher, T.
    Horakova, D.
    Havrdova, E. Kubala
    Izquierdo, G.
    Eichau, S.
    Patti, F.
    Prat, A. P.
    Girard, M.
    Duquette, P.
    Grammond, P.
    Onofrj, M.
    Lugaresi, A. L.
    Bergamaschi, R.
    Ozakbas, S.
    Grand'Maison, F.
    Hupperts, R.
    Sola, P.
    Ferraro, D.
    Sa, M. J.
    Kalincik, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 813 - 814
  • [5] Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis
    Cocco, E.
    Marchi, P.
    Sardu, C.
    Russo, P.
    Paolillo, A.
    Mascia, M. G.
    Solla, M.
    Frau, J.
    Lorefice, L.
    Massole, S.
    Floris, G.
    Marrosu, M. G.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (08) : 975 - 980
  • [6] Parity and disability progression in relapsing-remitting multiple sclerosis
    Achiron, Anat
    Ben-David, Alon
    Gurevich, Michael
    Magalashvili, David
    Menascu, Shay
    Dolev, Mark
    Stern, Yael
    Ziv-Baran, Tomer
    [J]. JOURNAL OF NEUROLOGY, 2020, 267 (12) : 3753 - 3762
  • [7] Daclizumab for the treatment of relapsing-remitting multiple sclerosis
    Herwerth, Marina
    Hemmer, Bernhard
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (06) : 747 - 753
  • [8] Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
    Fox, Edward J.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1789 - 1797
  • [9] Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
    Menge, Til
    Dubey, Divyanshu
    Warnke, Clemens
    Hartung, Hans-Peter
    Stuve, Olaf
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1131 - 1139
  • [10] Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
    Hersh, Carrie M.
    Cohen, Jeffrey A.
    [J]. IMMUNOTHERAPY, 2014, 6 (03) : 249 - 259
12345